M/s UCB Farchim SA v. M/s Cipla Ltd. & Ors., W.P.(C) No. 332 of 2010 (along with connected matters), Delhi High Court, decided on 8 February 2010
Background
Writ petitions before the Delhi High Court raised an important procedural question under Indian patent law: whether a writ petition under Article 226 of the Constitution is maintainable against an order of the Controller of Patents passed in pre-grant opposition proceedings under Section 25(1) of the Patents Act, 1970. The lead matter involved UCB Farchim SA, which had filed a patent application. Cipla filed a pre-grant opposition under Section 25(1). The Assistant Controller accepted the pre-grant opposition and refused to grant the patent. Instead of filing an appeal before the Intellectual Property Appellate Board (IPAB), UCB Farchim approached the Delhi High Court under Article 226 challenging the Controller’s order. Similar questions arose in connected petitions involving Eli Lilly, Yeda Research and Colorcon. In some cases, the Controller had rejected the pre-grant opposition and granted the patent; in others, the Controller had accepted the opposition and refused the patent. The core legal issue across all petitions was whether such orders could be challenged directly through writ jurisdiction or whether the parties were required to exhaust statutory remedies under the Patents Act.
The Court also examined the impact of the 2005 amendments to the Patents Act, which introduced post-grant opposition under Section 25(2) and appeals to the IPAB under Section 117A, as well as the Supreme Court’s decision in J. Mitra & Co. v. Assistant Controller of Patents.
Issue for Determination
The principal issue before the Court was whether a writ petition under Article 226 of the Constitution is maintainable against an order passed by the Controller of Patents in pre-grant opposition proceedings under Section 25(1) of the Patents Act. More specifically, the Court had to determine:
- Whether an applicant whose patent application was refused after acceptance of a pre-grant opposition must file an appeal before the IPAB under Section 117A.
- Whether a pre-grant opposer whose opposition was rejected has any statutory remedy.
- Whether the existence of an alternative statutory remedy bars invocation of writ jurisdiction.
Key Holding of the Court
The Delhi High Court held that writ petitions challenging orders passed in pre-grant opposition proceedings are generally not maintainable when an efficacious alternative statutory remedy exists. The Court clarified two important situations:
First, where a pre-grant opposition is rejected and the patent is granted, the opposer (if he is a “person interested”) has the statutory remedy of filing a post-grant opposition under Section 25(2) and thereafter an appeal under Section 117A to the IPAB if aggrieved. Such a person may also seek revocation under Section 64. Therefore, the existence of these remedies ordinarily bars a writ petition.
Second, where a pre-grant opposition is accepted and the Controller refuses to grant the patent, the refusal is in substance an order under Section 15 of the Patents Act. Since Section 117A provides an appeal to the IPAB against orders under Section 15, the patent applicant must approach the IPAB rather than the High Court under Article 226.
The Court emphasized that although the High Court has wide powers under Article 226, it will decline to exercise such jurisdiction where an effective alternative remedy exists. Accordingly, in the UCB Farchim matter and other connected petitions, the Court refused to entertain the writ petitions and directed the petitioners to file appeals before the IPAB.
Statutory Provisions Involved
The case involved interpretation of several key provisions of the Patents Act, 1970: Section 15 Empowers the Controller to refuse an application or require amendments if the application does not comply with the Act. Section 25(1) Provides for pre-grant opposition, which can be filed by “any person.” Section 25(2) Provides for post-grant opposition, which can be filed by a “person interested.”Section 25(4) Empowers the Controller to maintain, amend or revoke a patent after post-grant opposition. Section 64 Provides for revocation of a patent by a “person interested.” Section 117A Provides for appeal to the IPAB against specified orders, including orders under Section 15 and Section 25(4). The Court harmonized these provisions and clarified that refusal of a patent after pre-grant opposition is appealable under Section 117A as an order under Section 15.
Doctrinal Significance
This judgment is doctrinally significant because it clarifies the procedural architecture of opposition and appeal under the Patents Act after the 2005 amendments.
First, it draws a clear distinction between pre-grant and post-grant opposition. The Court described pre-grant opposition as being “in aid of examination,” meaning it assists the Controller before grant, whereas post-grant opposition is a structured adversarial proceeding involving an Opposition Board.
Second, the decision reinforces the doctrine of exhaustion of alternative remedies. Even though Article 226 grants wide powers, those powers are not to be exercised where the statute provides an adequate appellate mechanism.
Third, the judgment clarifies the scope of the Supreme Court’s ruling in J. Mitra & Co., explaining that it did not eliminate appellate remedies in all pre-grant situations. Instead, where the Controller refuses to grant a patent after accepting a pre-grant opposition, the order is effectively under Section 15 and therefore appealable to the IPAB.
Finally, the case strengthens the institutional role of the IPAB (as it then existed) as the specialized appellate forum for patent disputes, limiting direct recourse to constitutional courts in routine patent matters.Overall, the decision provides important guidance on the procedural pathway for patent applicants and opposers, ensuring that the statutory scheme of opposition and appeal is respected before invoking writ jurisdiction.